Prevent Diabetic Kidney Disease Among Egyptians

Fayoum University

Status: Not yet enrolling

Conditions: Diabetes Mellitus Without Complication

Treatments: Drug: Gliflozin

Study type: Observational

Funder types: Other

Identifiers

NCT06071208

VCG 6

Details and patient eligibility

About

Study of the possibility to prevent the development of Diabetic kidney disease in type 2 diabetic patients

Full description

Study of the possible role of the SGLT2 inhibitors to prevent the development of frank type2 DM among prediabetic candidates.

Study of the possible role of the SGLT2 inhibitors to prevent the development of diabetic complications, namely diabetic kidney disease, diabetic retinopathy and neuropathy.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• diabetics,prediabetics

Exclusion criteria

Trial design

10,000 participants in 2 patient groups

cases of study

Description:

Patients is diabetes whether recently discovered or long standing diabetes

Treatment:

Drug: Gliflozin

controls of study

Description:

prediabetics ,or patients with clinical manifestations of insulin resistance eg acanthosis negricans

Treatment:

Drug: Gliflozin